Comparing SR 95 → LR 166 — Recognize May 2025 as Amyotrophic Lateral Sclerosis Awaren...

Struck = only in SR 95 · added = only in LR 166.

Previous
Latest
Bill Text - SR-95 skip to content home accessibility FAQ feedback sitemap login x Quick Search:
LR166 LR166 2025 ONE HUNDRED NINTH LEGISLATURE FIRST SESSION LEGISLATIVE RESOLUTION 166   Introduced by Bosn, 25;
Bill Number Bill Keyword Home Bill Information California Law Publications Other Resources My Subscriptions My Favorites Bill Information >> Bill Search >> Text Bill Text PDF2 Bill PDF |Add To My Favorites |Track Bill | Version:
Andersen, 49;
05/12/26 - Enrolled 04/21/26 - Amended Senate 04/06/26 - Introduced SR-95 (2025-2026) Text >> Votes >> History >> Bill Analysis >> Today's Law As Amended >> Compare Versions >> Status >> Comments To Author >> Track Bill >> Add To My Favorites >> SHARE THIS:
Ballard, 21;
SR95:v97#DOCUMENTBill Start Enrolled  May 12, 2026 Passed  IN  Senate  May 11, 2026 Amended  IN  Senate  April 21, 2026 CALIFORNIA LEGISLATURE— 2025–2026 REGULAR SESSION Senate Resolution No.
Bostar, 29;
95Introduced by Senator Niello(Coauthors:
DeBoer, 10;
Senators Becker, Caballero, Choi, Dahle, Ochoa Bogh, Richardson, Seyarto, Strickland, Valladares, and Wahab)April 06, 2026Relative to Amyotrophic Lateral Sclerosis Awareness Month.
DeKay, 40;
LEGISLATIVE COUNSEL'S DIGESTSR 95, Niello.
Dorn, 30;
Digest KeyBill TextWHEREAS, Amyotrophic lateral sclerosis (ALS), also commonly referred to as Lou Gehrig’s disease, is a progressive fatal neurodegenerative disease in which a person’s brain loses connection with their muscles, slowly reducing a person’s ability to walk, talk, eat, and eventually breathe;
Dover, 19;
andWHEREAS, Thousands of new ALS cases are reported every year, and estimates show that every 90 minutes someone is diagnosed with ALS and someone passes away from ALS;
Hallstrom, 1;
andWHEREAS, On average, patients diagnosed with ALS survive only two to five years from the time of diagnosis;
Hansen, 16;
andWHEREAS, The exact causes of ALS are unknown and there is no known cure for ALS;
Holdcroft, 36;
andWHEREAS, People who have served in the military are more likely to develop ALS and die from the disease than those with no history of military service;
Kauth, 31;
andWHEREAS, Securing access to new therapies, durable medical equipment, and communication technologies is of vital importance to people living with ALS;
Lippincott, 34;
andWHEREAS, Clinical trials play a pivotal role in evaluating new treatments, enhancing quality of life, and fostering assistive technologies for those living with ALS;
Meyer, 17;
andWHEREAS, Amyotrophic Lateral Sclerosis Awareness Month provides an opportunity to increase public awareness of the dire circumstances of people living with ALS, acknowledge the terrible impact this disease has on those individuals and their families, and support research to eradicate this disease;
Murman, 38;
now, therefore, be itResolved by the Senate of the State of California, That the Senate hereby proclaims the month of May 2026 as Amyotrophic Lateral Sclerosis Awareness Month, and calls upon all Americans to join in supporting ALS research, advocating for increased funding, and standing in solidarity with those affected by this relentless disease;
Prokop, 27;
and be it furtherResolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.
Quick, 35;
Storm, 23.
WHEREAS, Amyotrophic Lateral Sclerosis (ALS), also commonly known as Lou Gehrig's disease, is a progressive fatal neurodegenerative disease in which a person's brain loses connection with their muscles, slowly reducing a person's ability to walk, talk, eat, and eventually breathe;
and WHEREAS, thousands of new ALS cases are reported every year, and estimates show that every ninety minutes, someone is diagnosed with ALS and someone passes away from ALS;
and WHEREAS, the exact cause of ALS is unknown and, on average, patients diagnosed with ALS survive only two to five years from the time of diagnosis;
and WHEREAS, securing access to new therapies, durable medical equipment, and communication technologies is of vital importance to people living with ALS;
and WHEREAS, clinical trials play a pivotal role in evaluating new treatments, enhancing quality of life, and fostering assistive technologies for those living with ALS;
and WHEREAS, Amyotrophic Lateral Sclerosis Awareness Month provides an opportunity to increase public awareness of the dire circumstances of people living with ALS, acknowledge the terrible impact this disease has on those individuals and their families, and support research to eradicate this disease.
NOW, THEREFORE, BE IT RESOLVED BY THE MEMBERS OF THE ONE HUNDRED NINTH LEGISLATURE OF NEBRASKA, FIRST SESSION:
1. That the Legislature recognizes May 2025 as ALS Awareness Month.
2.
That the Legislature encourages Nebraskans to join in supporting ALS -1- LR166 LR166 2025 research and funding and recognizes those affected by this relentless disease.
-2-